Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 1,436,000 | 1,338,000 | 1,233,000 | 1,093,000 | 1,305,000 |
| Cost of Goods | 1,139,000 | 1,025,000 | 976,000 | 894,000 | 1,007,000 |
| Gross Profit | 297,000 | 313,000 | 257,000 | 199,000 | 298,000 |
| Operating Expenses | 158,000 | 250,000 | 143,000 | 147,000 | 160,000 |
| Operating Income | 139,000 | 63,000 | 114,000 | 52,000 | 138,000 |
| Interest Expense | 49,000 | 50,000 | 53,000 | 53,000 | 54,000 |
| Other Income | 11,000 | 9,000 | -1,000 | 21,000 | -7,000 |
| Pre-tax Income | 101,000 | 22,000 | 60,000 | 20,000 | 77,000 |
| Income Tax | 5,000 | 3,000 | -16,000 | -4,000 | -23,000 |
| Net Income Continuous | 96,000 | 19,000 | 76,000 | 24,000 | 100,000 |
| Net Income | $96,000 | $19,000 | $76,000 | $24,000 | $100,000 |
| EPS Basic Total Ops | 0.58 | 0.11 | 0.46 | 0.15 | 0.61 |
| EPS Basic Continuous Ops | 0.58 | 0.11 | 0.46 | 0.15 | 0.61 |
| EPS Diluted Total Ops | 0.57 | 0.10 | 0.46 | 0.15 | 0.61 |
| EPS Diluted Continuous Ops | 0.57 | 0.11 | 0.46 | 0.15 | 0.61 |
| EBITDA(a) | $224,000 | $145,000 | $196,000 | $136,000 | $219,000 |